Stay updated on Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision indicator updates from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:52:37.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Access to the study page now shows a 403 Forbidden error, replacing the study content with an access-denied screen. The page content includes explicit 403 messaging and related HTML structure indicating forbidden access.
    Difference
    18%
    Check dated 2026-09-19T22:16:06.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows revision: v3.6.6, replacing v3.6.5, indicating a minor update to the page's documentation or underlying system. This change does not modify study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-29T19:42:18.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This appears to be a minor platform/documentation update with no visible changes to the trial details or content.
    Difference
    0.1%
    Check dated 2026-08-08T17:03:51.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.4, replacing the previous v3.6.3, indicating a minor update to the study record page. This appears to be a backend or formatting update rather than changes to the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-07-25T08:27:12.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    The page revision label updated to v3.6.3, replacing v3.6.2. This reflects a minor internal update to the study page without altering visible content.
    Difference
    0.1%
    Check dated 2026-07-03T22:53:38.000Z thumbnail image

Stay in the know with updates to Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Cabiralizumab in Pancreatic Cancer Clinical Trial page.